Literature DB >> 26926328

Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines.

Jai S Rudra1, Ye Ding1, Harshini Neelakantan1, Chunyong Ding1, Rajagopal Appavu1, Sonja Stutz1, Joshua D Snook1, Haiying Chen1, Kathryn A Cunningham1, Jia Zhou1.   

Abstract

The development of anti-cocaine vaccines that counteract the rewarding effects of the drug are currently being investigated as adjunct therapies for prevention of relapse in abstinent users. However, cocaine is weakly immunogenic and requires conjugation to carrier proteins and coadministration with strong adjuvants, which carry the risk of local reactogenicity and systemic toxicity. Here we report synthetic and multivalent self-assembling peptide nanofibers as adjuvant-free carriers for cocaine vaccines. A novel cocaine hapten modified at the P3 site was conjugated to the N-terminus of an amphipathic self-assembling domain KFE8. In aqueous buffers the cocaine-KFE8 conjugate assembled into β-sheet rich nanofibers, which raised anti-cocaine antibodies without the need for added adjuvants in mice. Vaccinated mice were treated with cocaine and a significant negative correlation was observed between antibody levels and cocaine-evoked hyperactivity. These totally synthetic and multivalent nanofibers with well-defined chemical composition represent the first generation of adjuvant-free cocaine vaccines.

Entities:  

Keywords:  Antibody; cocaine; hyperactivity; peptide-nanofiber; self-assembly; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26926328      PMCID: PMC4871789          DOI: 10.1021/acschemneuro.5b00345

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  28 in total

1.  Modulating adaptive immune responses to peptide self-assemblies.

Authors:  Jai S Rudra; Tao Sun; Katelyn C Bird; Melvin D Daniels; Joshua Z Gasiorowski; Anita S Chong; Joel H Collier
Journal:  ACS Nano       Date:  2012-01-30       Impact factor: 15.881

Review 2.  Modular design in natural and biomimetic soft materials.

Authors:  Aaron M Kushner; Zhibin Guan
Journal:  Angew Chem Int Ed Engl       Date:  2011-09-05       Impact factor: 15.336

Review 3.  Supramolecular chemical biology; bioactive synthetic self-assemblies.

Authors:  Katja Petkau-Milroy; Luc Brunsveld
Journal:  Org Biomol Chem       Date:  2012-11-19       Impact factor: 3.876

4.  Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Authors:  Frank M Orson; Roger D Rossen; Xiaoyun Shen; Angel Y Lopez; Yan Wu; Thomas R Kosten
Journal:  Am J Addict       Date:  2013-02-01

Review 5.  Vaccines against drug abuse.

Authors:  X Y Shen; F M Orson; T R Kosten
Journal:  Clin Pharmacol Ther       Date:  2011-11-30       Impact factor: 6.875

6.  The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.

Authors:  Jianjun Chen; Rebecca R Pompano; Felix W Santiago; Lea Maillat; Roger Sciammas; Tao Sun; Huifang Han; David J Topham; Anita S Chong; Joel H Collier
Journal:  Biomaterials       Date:  2013-08-13       Impact factor: 12.479

7.  Hapten optimization for cocaine vaccine with improved cocaine recognition.

Authors:  Muthu Ramakrishnan; Berma M Kinsey; Rana A Singh; Thomas R Kosten; Frank M Orson
Journal:  Chem Biol Drug Des       Date:  2014-07-29       Impact factor: 2.817

8.  Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model.

Authors:  Frances Valencia; Marcy J Bubar; Gregg Milligan; Kathryn A Cunningham; Nigel Bourne
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

9.  Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.

Authors:  Philip J Rybczynski; Roxanne E Zeck; Joseph Dudash; Donald W Combs; Thomas P Burris; Maria Yang; Melville C Osborne; Xiaoli Chen; Keith T Demarest
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

Review 10.  Applications of nanotechnology for immunology.

Authors:  Douglas M Smith; Jakub K Simon; James R Baker
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

View more
  16 in total

1.  Investigations into the efficacy of multi-component cocaine vaccines.

Authors:  Atsushi Kimishima; Margaret E Olson; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2017-12-20       Impact factor: 2.823

2.  A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers.

Authors:  Yaoying Wu; Pamela K Norberg; Elizabeth A Reap; Kendra L Congdon; Chelsea N Fries; Sean H Kelly; John H Sampson; Vincent P Conticello; Joel H Collier
Journal:  ACS Biomater Sci Eng       Date:  2017-09-11

Review 3.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

4.  Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.

Authors:  Cody J Wenthur; Xiaoqing Cai; Beverly A Ellis; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2017-07-05       Impact factor: 2.823

Review 5.  Bionanotechnology for vaccine design.

Authors:  Steven Frey; Ana Castro; Ammar Arsiwala; Ravi S Kane
Journal:  Curr Opin Biotechnol       Date:  2018-03-26       Impact factor: 9.740

6.  In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiangmeng Wu; Saiyang Hu; Subodh Kumar Samrat; Anil M Tharappel; Lili Kuo; David Butler; Yongcheng Song; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  Acta Pharm Sin B       Date:  2021-10-22       Impact factor: 14.903

7.  Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine.

Authors:  Zhen Zheng; Jillian L Kyzer; Adam Worob; Cody J Wenthur
Journal:  ACS Chem Neurosci       Date:  2021-10-15       Impact factor: 5.780

8.  Enabling sublingual peptide immunization with molecular self-assemblies.

Authors:  Sean H Kelly; Yaoying Wu; Ajay K Varadhan; Elizabeth J Curvino; Anita S Chong; Joel H Collier
Journal:  Biomaterials       Date:  2020-02-24       Impact factor: 12.479

9.  Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.

Authors:  Carolina Mora-Solano; Yi Wen; Huifang Han; Jianjun Chen; Anita S Chong; Michelle L Miller; Rebecca R Pompano; Joel H Collier
Journal:  Biomaterials       Date:  2017-09-26       Impact factor: 12.479

10.  Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins.

Authors:  Federico Baruffaldi; April Huseby Kelcher; Megan Laudenbach; Valeria Gradinati; Ajinkya Limkar; Michaela Roslawski; Angela Birnbaum; Andrew Lees; Carla Hassler; Scott Runyon; Marco Pravetoni
Journal:  Mol Pharm       Date:  2018-10-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.